What is KPTI's current stock price?

As of now, KPTI is trading at $6.19, with a daily change of +0.81%.

What are the risks associated with KPTI stock?

KPTI Key risk is its Moderate Risk Level, .

What is KPTI next earnings date?

KPTI next earnings report is scheduled for Nov 5, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

KPTI Stock Analysis & IQ Rating | Karyopharm Therapeutics

KPTI

Karyopharm Therapeutics

$6.19

+$0.05 | +0.81%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 16.95

MKT CAP

$ 98.59M

52W Low

$ 3.51

VOL

$ 90.16K

P/E Ratio

N/A

AVG VOL

$ 240.88K

RSI

51.61

TREND

Uptrend

KPTI Stock IQ

Login to see Karyopharm Therapeutics (KPTI) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

KPTI Target Price

Login to display

Strengths

KPTI Rewards

Upgraded on attractively valued

KPTI Rewards

Earnings are forecast to grow

Chart

$6.38 (-2.98%)

$4.02 (+53.98%)

$4.25 (+45.65%)

$0.89 (+595.51%)

1year

6month

3month

1month

KPTI Risk Level

KPTI has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Low volume

High volatilty

LOW

HIGH

KPTI Analysts Opinion

KPTI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

KPTI Analysts Opinion

KPTI Analysts opinion is positive and also has improved from the past 3 months

KPTI Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

KPTI Street Opinion

KPTI Street view is extremely bullish and have positive views on the near-term outlook

KPTI Performance Sentiment

Sentiments overview associated with KPTI events and the stock performance.

83%

0%

Positive

Negative

5 out of 6
events present

0 out of 6
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$6.40

Resistance
Price

$5.88

Current Price Range

$7.81

Show methods +

KPTI Earnings

The TTM reflects 12-month period, providing review of KPTI financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

137

145

146

-3.13%

Cost of Revenue

5

6

5

-

Gross Profit

132

139

141

-3.24%

Operating Exp

247

259

271

-4.53%

Operating Inc

-115

-119

-130

-

Net Interest Inc

-40

-30

-13

-

Interest Exp

45

37

24

+36.93%

Interest Inc

5

7

11

-32.58%

Other Inc Exp

32

73

-

EPS Growth

-14.84

-9.45

-18.75

-

KPTI Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

2.75

Next Earnings Date: Nov 5, 2025

KPTI Latest Analysis +

FAQ About KPTI Stock Insights

What is KPTI current stock price?

What are KPTI stock strengths?

What risks are associated with KPTI stock?

When is KPTI next earnings report?

What is KPTI market cap and volume?

What is KPTI's current Stock IQ?

Should I buy KPTI stock right now?

Is KPTI a Strong Buy right now?

What does a 'Strong Buy' rating mean for KPTI?

What does a 'Strong Sell' rating mean for KPTI?

What factors influence KPTI's Stock IQ?

Explore our KPTI Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored KPTI Stock Strategies
Effective Risk Management

FIND US ON

Receive our KPTI Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

KPTI

Karyopharm Therapeutics

Current Price

$6.19

+$0.05 | +0.81%

52W High

$ 16.95

MKT CAP

$ 98.59M

52W Low

$ 3.51

VOL

$ 90.16K

P/E Ratio

N/A

AVG VOL

$ 240.88K

RSI

51.61

TREND

Uptrend

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

KPTI Rewards

Upgraded on attractively valued

KPTI Rewards

Earnings are forecast to grow

KPTI Stock IQ

Login to unlock Karyopharm Therapeutics (KPTI) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$6.38 (-2.98%)

$4.02 (+53.98%)

$4.25 (+45.65%)

$0.89 (+595.51%)

1year

6month

3month

1month

KPTI Analysts Opinion

KPTI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

KPTI Analysts Opinion

KPTI Analysts opinion is positive and also has improved from the past 3 months

KPTI Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

KPTI Street Opinion

KPTI Street view is extremely bullish and have positive views on the near-term outlook

KPTI Risk Level

KPTI has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Low volume

High volatilty

LOW

HIGH

KPTI Performance Sentiment

Sentiments overview associated with KPTI events and the stock performance.

83%

0%

Positive

Negative

5 out of 6
events present

0 out of 6
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$6.40

Resistance
Price

$5.88

Current Price Range

$7.81

Show methods +

KPTI Earnings

The TTM data reflects the most recent 12-month period, providing overview of KPTI financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

137

145

146

-3.13%

Cost of Revenue

5

6

5

-

Gross Profit

132

139

141

-3.24%

Operating Exp

247

259

271

-4.53%

Operating Inc

-115

-119

-130

-

Net Interest Inc

-40

-30

-13

-

Interest Exp

45

37

24

+36.93%

Interest Inc

5

7

11

-32.58%

Other Inc Exp

32

73

-

EPS Growth

-14.84

-9.45

-18.75

-

KPTI Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

2.75

Next Earnings Date: Nov 5, 2025

KPTI Latest Analysis

Karyopharm Therapeutics (KPTI)s Technical Outlook is Bright After Key Golden Cross. Is it a good or bad thing when a stock experiences a golden cross technical event?

Fri Oct 17, 2025

$5.99 | -1.66%

Potential

Technical

HC Wainwright & Co. Upgrades Karyopharm Therapeutics (KPTI). Fintel reports that on October 13 2025 HC Wainwright &. Co. upgraded their outlook for Karyopharm Therapeutics (NasdaqGS:KPTI) from Neutral to Buy. Analyst Price Forecast Suggests 226.40% Upside

Mon Oct 13, 2025

$5.62 | +2.18%

Potential

Rating

Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026. KPTI) on Wednesday announcedcomprehensive financing and capital structure transactions expected to provide the company with $100 million of financial flexibility and additional capital extending the cash runway into the second quarter of 2026.KPTI is among today’.s weakest performers. Karyopharm said it continues exploring potential financing and strategic alternatives to enhance liquidity and

Wed Oct 8, 2025

$5.90 | +2.25%

Activity

Karyopharm rises on securing $100M in financing to extend cash runway into Q2 2026.

Wed Oct 8, 2025

$5.90 | +2.25%

Momentum

Discover KPTI Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of KPTI. We're here to help you make informed investment decisions today.

FIND US ON

Receive our KPTI Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

KPTI Stock trends

KPTI Stock performance

KPTI Stock analysis

KPTI investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing KPTI

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing KPTI

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

KPTI Stock Analysis & IQ Rating | Karyopharm Therapeutics

KPTI Stock IQ

KPTI Target Price

KPTI Risk Level

KPTI Analysts Opinion

KPTI Street Consensus

KPTI Performance Sentiment

Technical Price Levels

KPTI Financial Health

Explore our KPTI Stock insights

Receive our KPTI Daily Alerts

KPTI Stock IQ

KPTI Street Consensus

KPTI Risk Level

Technical Price Levels

Discover KPTI Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of KPTI. We're here to help you make informed investment decisions today.

Receive our KPTI Daily Alerts

KPTI Runner Alarm